Nouman, Maryum <br/><br/>
Response Rate of Cisplatin Plus Docetaxel as Primary Treatment in Locally Advanced Head and Neck Carcinoma (Squamous Cell Types).  [electronic resource] 

 -  Asian Pacific journal of cancer prevention : APJCP  Mar 2020 
 - 825-830 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2476-762X 
<br/><br/><label>Standard No.: </label>10.31557/APJCP.2020.21.3.825  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cisplatin--administration & dosage<br/>Disease Progression<br/>Docetaxel--administration & dosage<br/>Female<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Squamous Cell Carcinoma of Head and Neck--drug therapy<br/>Treatment Outcome